43 research outputs found
Inflammation-induced Id2 promotes plasticity in regulatory T cells
T(H)17 cells originating from regulatory T (T-reg) cells upon loss of the T-reg-specific transcription factor Foxp3 accumulate in sites of inflammation and aggravate autoimmune diseases. Whether an active mechanism drives the generation of these pathogenic 'ex-Foxp3 T(H)17' cells, remains unclear. Here we show that pro-inflammatory cytokines enhance the expression of transcription regulator Id2, which mediates cellular plasticity of T-reg into 'ex-Foxp3' T(H)17 cells. Expression of Id2 in in vitro differentiated iT(reg) cells reduces the expression of Foxp3 by sequestration of the transcription activator E2A, leading to the induction of T(H)17-related cytokines. T-reg-specific ectopic expression of Id2 in mice significantly reduces the T-reg compartment and causes immune dysregulation. Cellular fate-mapping experiments reveal enhanced T-reg plasticity compared to wild-type, resulting in exacerbated experimental autoimmune encephalomyelitis pathogenesis or enhanced anti-tumor immunity. Our findings suggest that controlling Id2 expression may provide a novel approach for effective T-reg cell immunotherapies for both autoimmunity and cancer.11sciescopu
Dietary Glucose Consumption Promotes RALDH Activity in Small Intestinal CD103(+)CD11b(+) Dendritic Cells
Retinal dehydrogenase (RALDH) enzymatic activities catalyze the conversion of
vitamin A to its metabolite Retinoic acid (RA) in intestinal dendritic cells (DCs)
and promote immunological tolerance. However, precise understanding of the exogenous
factors that act as initial trigger of RALDH activity in these cells is still
evolving. By using germ-free (GF) mice raised on an antigen free (AF) elemental
diet, we find that certain components in diet are critically required to establish
optimal RALDH expression and activity, most prominently in small intestinal
CD103(+)CD11b(+) DCs (siLP-DCs) right from the beginning of their lives.
Surprisingly, systematic screens using modified diets devoid of individual dietary
components indicate that proteins, starch and minerals are dispensable for this
activity. On the other hand, in depth comparison between subtle differences in
dietary composition among different dietary regimes reveal that adequate glucose
concentration in diet is a critical determinant for establishing RALDH activity
specifically in siLP-DCs. Consequently, pre-treatment of siLP-DCs, and not
mesenteric lymph node derived MLNDCs with glucose, results in significant
enhancement in the in vitro generation of induced Regulatory T (iTreg) cells. Our
findings reveal previously underappreciated role of dietary glucose concentration in
establishing regulatory properties in intestinal DCs, thereby extending a potential
therapeutic module against intestinal inflammation11Ysciescopu
Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness
Breast cancer is highly aggressive and is the leading cause of cancer-related mortality in women in developed countries. The ETS proto-oncogene 1 (Ets1) has versatile roles during the cellular processes of cancer development. It is often highly expressed in breast cancers and mediates migration and invasion of human breast cancer cells. However, underlying mechanisms of Ets1 gene expression is still ambiguous. Here, we identified a core-regulatory element (CRE) located in the Ets1 promoter region (−540/−80 bp from TSS) that contains elements responsible for associating with NFATs and NF-κBs. Compared with the less metastatic breast cancer cells, metastatic breast cancer cells (MDA-MB-231) show open chromatin configurations in the CRE, which facilitates direct binding of NFATc2 and/or NFKB1/RELA complex to trans-activate Ets1 transcription. Moreover, enhanced level of Nfatc2 and Nfkb1 positively correlated with Ets1 expression in the human breast cancer specimens. Deletion of the CRE region by CRISPR/Cas9 system resulted in significant reduction in Ets1 expression, which led to alterations of Ets1-mediated transcription programs including tumor invasiveness-related genes. Proper regulation of Ets1 gene expression by targeting the NFATc2 and NFKB1/RELA interaction could be a potential therapeutic target for Ets1-mediated metastatic breast cancer.11sciescopu
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
CD4+Foxp3+ regulatory T-cells (Tregs) are a unique subset of helper T-cells, which regulate immune response and establish peripheral tolerance. Tregs not only maintain the tone and tenor of an immune response by dominant tolerance but, in recent years, have also been identified as key players in resolving tissue inflammation and as mediators of tissue healing. Apart from being diverse in their origin (thymic and peripheral) and location (lymphoid and tissue resident), Tregs are also phenotypically heterogeneous as per the orientation of ongoing immune response. In this review, we discuss the recent advances in the field of Treg biology in general, and non-lymphoid and tissue-resident Tregs in particular. We elaborate upon well-known visceral adipose tissue, colon, skin, and tumor-infiltrating Tregs and newly identified tissue Treg populations as in lungs, skeletal muscle, placenta, and other tissues. Our attempt is to differentiate Tregs based on distinctive properties of their location, origin, ligand specificity, chemotaxis, and specific suppressive mechanisms. Despite ever expanding roles in maintaining systemic homeostasis, Tregs are employed by large varieties of tumors to dampen antitumor immunity. Thus, a comprehensive understanding of Treg biology in the context of inflammation can be instrumental in effectively managing tissue transplantation, autoimmunity, and antitumor immune responses
A CURIous Case of Molecular Kidnapping
In this issue of Molecular Cell, Albert et al. (2016) demonstrate how the production of rRNA and ribosomal proteins is coordinated through a two-step response to stress that requires cross-talk between a dedicated transcription factor and a ribosome assembly factor. (c) 2016 Elsevier Inc.
Regulatory T cells as therapeutic targets and mediators
With the advent of the concept of dominant tolerance and the subsequent discovery of
CD4þ regulatory T cells expressing the transcription factor FOXP3 (Tregs), almost all productive
as well as nonproductive immune responses can be compartmentalized to a binary of
immune effector T cells and immune regulatory Treg populations. A beneficial immune
response warrants the timely regulation by Tregs, whereas a nonproductive immune
response indicates insufficient effector functions or an outright failure of tolerance. There
are ample reports supporting role of Tregs in suppressing spontaneous auto-immune diseases
as well as promoting immune evasion by cancers. To top up their importance, several
non-immune functions like tissue homeostasis and regeneration are also being attributed to
Tregs. Hence, after being in the center stage of basic and translational immunological
research, Tregs are making the next jump towards clinical studies. Therefore, newer small
molecules, biologics as well as adoptive cell therapy (ACT) approaches are being tested to
augment or undermine Treg responses in the context of autoimmunity and cancer. In this
brief review, we present the strategies to modulate Tregs towards a favorable clinical
outcome. c. 2019 Taylor & Francis Group, LLC11sciescopu
Signaling networks controlling ID and E protein activity in T cell differentiation and function
E and inhibitor of DNA binding (ID) proteins are involved in various cellular developmental processes and effector activities in T cells. Recent findings indicate that E and ID proteins are not only responsible for regulating thymic T cell development but also modulate the differentiation, function, and fate of peripheral T cells in multiple immune compartments. Based on the well-established E and ID protein axis (E-ID axis), it has been recognized that ID proteins interfere with the dimerization of E proteins, thus restricting their transcriptional activities. Given this close molecular relationship, the extent of expression or stability of these two protein families can dynamically affect the expression of specific target genes involved in multiple aspects of T cell biology. Therefore, it is essential to understand the endogenous proteins or extrinsic signaling pathways that can influence the dynamics of the E-ID axis in a cell-specific and context-dependent manner. Here, we provide an overview of E and ID proteins and the functional outcomes of the E-ID axis in the activation and function of multiple peripheral T cell subsets, including effector and memory T cell populations. Further, we review the mechanisms by which endogenous proteins and signaling pathways alter the E-ID axis in various T cell subsets influencing T cell function and fate at steady-state and in pathological settings. A comprehensive understanding of the functions of E and ID proteins in T cell biology can be instrumental in T cell-specific targeting of the E-ID axis to develop novel therapeutic modalities in the context of autoimmunity and cancer.11Ysciescopu
Potential Interface between Ribosomal Protein Production and Pre-rRNA Processing▿
It has become clear that in Saccharomyces cerevisiae the transcription of ribosomal protein genes, which makes up a major proportion of the total transcription by RNA polymerase II, is controlled by the interaction of three transcription factors, Rap1, Fhl1, and Ifh1. Of these, only Rap1 binds directly to DNA and only Ifh1 is absent when transcription is repressed. We have examined further the nature of this interaction and find that Ifh1 is actually associated with at least two complexes. In addition to its association with Rap1 and Fhl1, Ifh1 forms a complex (CURI) with casein kinase 2 (CK2), Utp22, and Rrp7. Fhl1 is loosely associated with the CURI complex; its absence partially destabilizes the complex. The CK2 within the complex phosphorylates Ifh1 in vitro but no other members of the complex. Two major components of this complex, Utp22 and Rrp7, are essential participants in the processing of pre-rRNA. Depletion of either protein, but not of other proteins in the early processing steps, brings about a substantial increase in ribosomal protein mRNA. We propose a model in which the CURI complex is a key mediator between the two parallel pathways necessary for ribosome synthesis: the transcription and processing of pre-rRNA and the transcription of ribosomal protein genes